The original paper ''Folate-conjugated chitosan-polylactide nanoparticles for enhanced intracellular uptake of anticancer drug'' was published in the Journal of Nanoparticle Research, 2013 Research, , 15:2096 . The description for the synthesis of folate-conjugated chitosanpolylactide (FA-CH-PCL), which appeared in the page 3 of 15, right column, lines: 11-35, was not correct and is replaced with the following statement.
''Polylactide (PLA) was grafted onto CH following group-protection methods with some modifications (Duan et al. 2010; Zhou et al. 2013; Feng and Dong 2007) . In a typical procedure, 1 g of CH was dissolved in 30 mL of methanesulfonic acid, followed by addition of 2.57 g of LA monomer and 0.73 g of 4-dimethylaminopyridine. The reaction was allowed to perform for 12 h at 120°C with stirring while bubbling with nitrogen. The resulting mixture was then transferred to a beaker that contained 200 mL of 0.2 M KH 2 PO 4 , 20 mL of 4 M NaOH and was cooled in a bath (0°C) to remove the acid residue. The collected precipitate was extracted with toluene to remove PLA homopolymers. Afterward, the product was dialyzed against distilled water for 2 days using a membrane tube (MW cutoff: 10 kD) and lyophilized for further use. By mainly changing the feed ratio of LA to CH, several types of CH-PLA copolymers were synthesized using the same protocol. Folate was then conjugated onto CH-PLAs using the method as the same as that described in the synthesis of FA-CH and FA-substitution degree for FA-CH-PLAs was controlled around 10 wt% or lower.'' 
